kneat.com (KSI) Panoramica del titolo
kneat.com, inc. insieme alle sue consociate, progetta, sviluppa e fornisce software per la gestione di dati e documenti in ambienti regolamentati in Nord America, Europa e Asia Pacifico. Maggiori dettagli
| Punteggio fiocco di neve | |
|---|---|
| Valutazione | 2/6 |
| Crescita futura | 1/6 |
| Prestazioni passate | 0/6 |
| Salute finanziaria | 4/6 |
| Dividendi | 0/6 |
KSI Community Fair Values
Create NarrativeSee what 15 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Concorrenti di kneat.com, inc.
Storia dei prezzi e prestazioni
| Prezzi storici delle azioni | |
|---|---|
| Prezzo attuale dell'azione | CA$6.47 |
| Massimo di 52 settimane | CA$6.50 |
| Minimo di 52 settimane | CA$3.23 |
| Beta | 1.35 |
| Variazione di 1 mese | 0.31% |
| Variazione a 3 mesi | 46.38% |
| Variazione di 1 anno | 13.51% |
| Variazione a 3 anni | 112.13% |
| Variazione a 5 anni | 112.83% |
| Variazione dall'IPO | 1,748.57% |
Notizie e aggiornamenti recenti
Aggiornamento narrativa • Jun 24
KSI: Pending Thoma Bravo Buyout Will Frame Fairly Valued Upside And Risks
The updated analyst fair value estimate for kneat.com edges up to CA$6.35 from CA$6.10, reflecting price targets that have converged around the CA$6.50 cash offer as analysts adjust their views following the proposed acquisition by an affiliate of Thoma Bravo. Analyst Commentary Recent street research on kneat.com has clustered around the proposed C$6.50 cash offer, with analysts updating ratings and targets to reflect the pending acquisition and a narrower range of potential outcomes for the stock.Aggiornamento narrativa • Jun 07
KSI: Life Sciences Validation Adoption And Committee Review Will Support Future Upside
Analyst price targets for kneat.com have shifted higher into a CA$5.75 to CA$6.25 range, reflecting updated views on fair value at CA$6.10, a revised future P/E of about 51x, improved profit margin assumptions, and recent Street research updates from multiple firms. Analyst Commentary Bullish Takeaways Bullish analysts are aligning around a CA$5.75 to CA$6.25 price target range, which signals confidence in the updated fair value assumption of about CA$6.10 relative to the current fundamentals.Recent updates
Aggiornamento narrativa • Jun 24
KSI: Pending Thoma Bravo Buyout Will Frame Fairly Valued Upside And Risks
The updated analyst fair value estimate for kneat.com edges up to CA$6.35 from CA$6.10, reflecting price targets that have converged around the CA$6.50 cash offer as analysts adjust their views following the proposed acquisition by an affiliate of Thoma Bravo. Analyst Commentary Recent street research on kneat.com has clustered around the proposed C$6.50 cash offer, with analysts updating ratings and targets to reflect the pending acquisition and a narrower range of potential outcomes for the stock.Aggiornamento narrativa • Jun 07
KSI: Life Sciences Validation Adoption And Committee Review Will Support Future Upside
Analyst price targets for kneat.com have shifted higher into a CA$5.75 to CA$6.25 range, reflecting updated views on fair value at CA$6.10, a revised future P/E of about 51x, improved profit margin assumptions, and recent Street research updates from multiple firms. Analyst Commentary Bullish Takeaways Bullish analysts are aligning around a CA$5.75 to CA$6.25 price target range, which signals confidence in the updated fair value assumption of about CA$6.10 relative to the current fundamentals.Aggiornamento narrativa • May 13
KSI: Life Sciences Validation Adoption And Special Committee Review Will Support Future Upside
Analysts have increased the fair value estimate for kneat.com from CA$5.70 to CA$5.90, aligning it with recent Street price target adjustments in the CA$5.50 to CA$6.25 range and reflecting views on the company's growth profile, margins and P/E expectations. Analyst Commentary Recent Street research around kneat.com has focused on recalibrating price targets while keeping positive ratings in place.Aggiornamento narrativa • Apr 21
KSI: Pharma Packaging Agreements And Data Integrity Adoption Will Support Future Upside
Narrative Update Analysts have trimmed their blended price target on kneat.com by CA$1.00 to CA$5.50, reflecting recent target cuts from CA$6.50, while still citing supportive views on the business outlook. Analyst Commentary Recent research suggests that while price targets on kneat.com have been reset to CA$5.50, the general tone from covering firms still leans supportive, with ratings such as Buy and Outperformer maintained alongside a fresh, constructive initiation.Aggiornamento narrativa • Apr 05
KSI: Global Pharma Agreements And Data Integrity Adoption Will Support Future Margin Expansion
Analysts have trimmed their average price target on kneat.com to CA$5.50 from CA$6.50, citing refreshed assumptions around discount rates, long term growth expectations and valuation multiples, while generally maintaining positive ratings on the shares. Analyst Commentary Recent research on kneat.com points to a reset in expectations, with price targets grouped around CA$5.50 and ratings that remain generally constructive on the company’s execution and growth potential.Aggiornamento narrativa • Mar 21
KSI: Data Integrity Adoption And New Pharma Wins Will Support Future Margin Expansion
The analyst price target for kneat.com has been trimmed to CA$5.50 from CA$6.50. Analysts are factoring in an updated fair value of CA$5.70, a modestly higher discount rate, and adjusted revenue growth and profit margin assumptions, while still citing generally positive research commentary on the shares.Aggiornamento narrativa • Mar 07
KSI: Data Integrity Adoption Will Support Future Margin Expansion Despite Reset Expectations
Analysts have reduced their fair value estimate for kneat.com to CA$5.75 from CA$6.67. This change reflects recent cuts to Street price targets to around CA$5.50 and more cautious assumptions on growth, margins, and future P/E.Aggiornamento narrativa • Feb 20
KSI: Data Integrity Adoption Will Support Future Margin Expansion Potential
Analysts have maintained their CA$6.67 price target on kneat.com, citing supportive TD Securities research. The research highlights the company’s growth profile and long-term margin potential, as reflected in modest adjustments to the discount rate, revenue growth, and future P/E assumptions.Aggiornamento narrativa • Feb 06
KSI: Global Validation Wins And Bullish Coverage Will Support Future Upside
Analysts have trimmed their price expectations for kneat.com, with recent targets moving from C$7.50 to C$5.50 and from C$8.50 to C$7.50. This reflects updated views on fair value, profitability assumptions and future P/E levels, while a new bullish initiation from TD Securities highlights ongoing interest in the name.Aggiornamento narrativa • Jan 23
KSI: Global Validation Agreements Will Support Future Upside Despite Lowered Street Expectations
Narrative update on kneat.com The analyst price target for kneat.com has been revised lower to C$5.50 to C$7.50, down from C$7.50 to C$8.50, as analysts adjust their views while maintaining positive ratings on the shares. Analyst Commentary Recent research reflects a mixed but generally constructive stance on kneat.com, with both supporting and cautionary points tied to the revised price targets of C$5.50 and C$7.50 and the maintained positive ratings.Aggiornamento narrativa • Jan 08
KSI: Global Validation Agreements Will Support Future Upside Despite Recent Estimate Revisions
Analysts nudged their fair value estimate for kneat.com to C$6.80 from C$6.60. Recent Street price target updates to C$5.50 and C$7.50 helped frame the new outlook on discount rates, revenue growth, profit margins and future P/E assumptions.Aggiornamento narrativa • Dec 15
KSI: Expanding Global Validation Agreements Will Drive Future Outperformance
We lower our Kneat.com price target to C$5.50 from C$7.50, reflecting analysts' reduced near term expectations for valuation multiples, despite largely unchanged long term growth and margin assumptions. Analyst Commentary Recent Street research reflects a more tempered near term outlook for Kneat.com, with price targets revised lower but positive ratings maintained, signaling continued confidence in the company’s underlying growth trajectory.Aggiornamento narrativa • Dec 01
KSI: Expansion Of Global Customer Agreements Will Drive Outperformance Ahead
Analysts have reduced their average price target for kneat.com from $6.80 to $6.60. This change is attributed to recent downward revisions to growth and profit forecasts.Articolo di analisi • Nov 18
Market Cool On kneat.com, inc.'s (TSE:KSI) Revenues Pushing Shares 26% Lower
The kneat.com, inc. ( TSE:KSI ) share price has fared very poorly over the last month, falling by a substantial 26...Aggiornamento narrativa • Nov 17
KSI: Momentum In Securing New Customers Will Drive Performance Ahead
Analysts have lowered their price targets for kneat.com. Target estimates have decreased from C$8.50 and C$7.50 previously to updated levels of C$7.50 and C$5.50 respectively, citing slower expected revenue growth and a slightly higher discount rate as key factors in their revised outlook.
Nuova narrativa • Mar 29
Life Sciences Wins And Expanded Sales Will Open Future Markets
Strategic wins and expansions in multiple sectors, alongside enhanced AI tools, are expected to boost revenue and improve net margins.Articolo di analisi • Mar 01
kneat.com, inc. (TSE:KSI) Just Reported And Analysts Have Been Lifting Their Price Targets
It's been a pretty great week for kneat.com, inc. ( TSE:KSI ) shareholders, with its shares surging 15% to CA$6.88 in...Articolo di analisi • Feb 22
A Look At The Intrinsic Value Of kneat.com, inc. (TSE:KSI)
Key Insights The projected fair value for kneat.com is CA$5.19 based on 2 Stage Free Cash Flow to Equity Current share...Articolo di analisi • May 11
Investors Still Waiting For A Pull Back In kneat.com, inc. (TSE:KSI)
With a price-to-sales (or "P/S") ratio of 10.1x kneat.com, inc. ( TSE:KSI ) may be sending very bearish signals at the...Articolo di analisi • Nov 08
Is kneat.com (TSE:KSI) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Articolo di analisi • Aug 04
Here's Why We're Not Too Worried About kneat.com's (TSE:KSI) Cash Burn Situation
Just because a business does not make any money, does not mean that the stock will go down. For example, although...Articolo di analisi • Jun 30
Fewer Investors Than Expected Jumping On kneat.com, inc. (TSE:KSI)
There wouldn't be many who think kneat.com, inc.'s ( TSE:KSI ) price-to-sales (or "P/S") ratio of 8.7x is worth a...Rendimenti per gli azionisti
| KSI | CA Healthcare Services | CA Mercato | |
|---|---|---|---|
| 7D | 0.2% | -5.8% | 0.3% |
| 1Y | 13.5% | -12.1% | 28.3% |
Ritorno vs Industria: KSI ha superato il Canadian Healthcare Services che ha restituito -12.1 % nell'ultimo anno.
Rendimento vs Mercato: KSI ha avuto una performance inferiore al mercato Canadian che ha registrato un rendimento 28.3 % nell'ultimo anno.
Volatilità dei prezzi
| KSI volatility | |
|---|---|
| KSI Average Weekly Movement | 6.5% |
| Healthcare Services Industry Average Movement | 9.1% |
| Market Average Movement | 9.5% |
| 10% most volatile stocks in CA Market | 16.6% |
| 10% least volatile stocks in CA Market | 3.6% |
Prezzo delle azioni stabile: KSI non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi rispetto al mercato Canadian.
Volatilità nel tempo: La volatilità settimanale ( 7% ) di KSI è rimasta stabile nell'ultimo anno.
Informazioni sull'azienda
| Fondato | I dipendenti | AMMINISTRATORE DELEGATO | Sito web |
|---|---|---|---|
| 2007 | 343 | Eddie Ryan | kneat.com |
kneat.com, inc. insieme alle sue consociate, progetta, sviluppa e fornisce software per la gestione di dati e documenti in ambienti regolamentati in Nord America, Europa e Asia Pacifico. L'azienda offre la piattaforma Kneat Gx, un'applicazione configurabile off-the-shelf incentrata sulla gestione del ciclo di vita della convalida e sui test per le industrie biotecnologiche, farmaceutiche e di produzione di dispositivi medici. La piattaforma viene utilizzata in varie applicazioni, tra cui la gestione dei documenti, la convalida degli strumenti analitici, la convalida dei metodi, la messa in servizio e la qualificazione, la gestione dei disegni, la convalida delle utenze e delle strutture, la convalida della catena del freddo, la gestione del registro elettronico, la convalida dei processi, la convalida dei sistemi informatici e la convalida della pulizia.
kneat.com, inc. Riepilogo dei fondamenti
| KSI statistiche fondamentali | |
|---|---|
| Capitalizzazione di mercato | CA$622.57m |
| Utili (TTM) | -CA$8.44m |
| Ricavi(TTM) | CA$66.52m |
9.4x
Rapporto P/S-73.8x
Rapporto P/EKSI è sopravvalutato?
Vedi Fair Value e analisi di valutazioneUtili e ricavi
| KSI Conto economico (TTM) | |
|---|---|
| Ricavi | CA$66.52m |
| Costo del fatturato | CA$15.54m |
| Profitto lordo | CA$50.97m |
| Altre spese | CA$59.41m |
| Utili | -CA$8.44m |
Ultimi utili riportati
Mar 31, 2026
Prossima data di guadagno
n/a
| Utile per azione (EPS) | -0.088 |
| Margine lordo | 76.63% |
| Margine di profitto netto | -12.69% |
| Rapporto debito/patrimonio netto | 31.6% |
Come si è comportato KSI nel lungo periodo?
Vedi performance storica e confrontoAnalisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/07/23 02:22 |
| Prezzo dell'azione a fine giornata | 2026/07/23 00:00 |
| Utili | 2026/03/31 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina GitHub; abbiamo anche delle guide su come utilizzare i nostri report e dei tutorial su YouTube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
kneat.com, inc. è coperta da 9 analisti. 5 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Gavin Fairweather | ATB Cormark |
| Douglas Taylor | Canaccord Genuity |
| Stephanie Price | CIBC Capital Markets |